04/15/2026
Here’s a common question I hear: If peptides are so effective, why aren’t they all FDA-approved?
The answer is more nuanced than most people think.
Peptides themselves are not new; many have been studied and even used in parts of Europe for decades.
But in the U.S., only a small number are FDA-approved, largely because many peptides lack large-scale human clinical trials required for full regulatory approval.
And that matters.
In the past, peptides were often used without proper oversight or standardization, sometimes sourced from unregulated markets, which raised real concerns around safety, dosing, and quality. This is one of the reasons regulations became stricter.
So while some peptides are promising, approval isn’t just about potential. It’s about evidence, consistency, and patient safety.
As physicians, this is where responsibility comes in: understanding the science, the limitations, and most importantly, when and for whom something is appropriate.
Did this perspective surprise you? What questions do you still have about peptides?
Message me PEPTIDES and let's continue the conversation!
